(HealthDay News) — For patients who require permanent single-chamber ventricular pacing, an active-fixation leadless cardiac pacemaker is safe and effective, according to a study published online ...
This story is part of a series on the current progression in Regenerative Medicine. This piece discusses the regeneration of the cardiovascular system. In 1999, I defined regenerative medicine as the ...
A novel leadless cardiac pacemaker demonstrates stable performance and reassuring safety over 1 year after implantation, according to results from a small study published in the April 21, 2015, issue ...
PHILADELPHIA — Accelerometer-based atrial sensing with a novel, enhanced, automated algorithm in patients with atrioventricular block and a single-chamber leadless pacemaker in the right ventricle ...
Every once in a while, a breakthrough doesn't just advance medicine—it changes the conversation entirely. SUNNYVALE, Calif., April 17, 2025 /PRNewswire/ -- EBR Systems, Inc. (ASX: EBR) has received ...
ABBOTT PARK, Ill., Nov. 12, 2021 /PRNewswire/ -- Abbott (NYSE: ABT) today announced new, late-breaking data from the global Leadless II IDE study evaluating Abbott's investigational Aveir leadless ...
Currently under review at the FDA, Abbott’s miniaturized, leadless pacemaker has aced a clinical study by showing it could speed up the beat of a patient’s heart once its rhythm falls out of sync. The ...
Cardiology, well into the age of leadless pacemakers, could be headed for an age of leadless pacemaker systems in which various pacing functions are achieved by multiple implants that "talk" to each ...
BOSTON -- A leadless pacemaker reliably communicated with a subcutaneous implantable cardioverter-defibrillator (S-ICD) to deliver anti-tachycardia (ATP) and bradycardia pacing, the MODULAR ATP study ...
Please provide your email address to receive an email when new articles are posted on . Abbott announced that the FDA has approved its Aveir VR single-chamber leadless pacemaker for the treatment of ...
An experimental leadless pacemaker is able to capture enough energy from the heart to partially power the device, according to results from a new proof-of-concept study. The prototype device harvested ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results